Clobazam Tablets 10mg — Class II drug recall D-0348-2024
Ongoing recall by Micro Labs Limited, reported 2024-02-28, distributed nationwide. CGMP Deviations: Out of specification for residual solvents.
| Recall number | D-0348-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Micro Labs Limited, Verna, N/A, India |
| Recall initiated | 2024-02-12 |
| Classified | 2024-02-22 |
| Reported by FDA | 2024-02-28 |
| Distributed | Nationwide (US) |
| Quantity | 24,768 bottles |
| Reason classes | cgmp, specification failure |
| NDC | 42571-0315, 42571-0315-01, 42571-0315-05, 42571-0315-11, 42571-0315-20, 42571-0315-30, 42571-0315-32, 42571-0315-90, 42571-0315-91, 42571-0316, 42571-0316-01, 42571-0316-11, 42571-0316-20, 42571-0316-30, 42571-0316-32, 42571-0316-90, 42571-0316-91 |
Product
Clobazam Tablets 10mg, 100-count bottle, Rx Only, Manufactured by: Micro Labs Limited Goa-403 722, India. Manufactured for: Micro Labs USA, Inc. Somerset, NJ 08873. NDC 42571-315-01
Reason for recall
CGMP Deviations: Out of specification for residual solvents.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0348-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.